Fibromyalgia and Medical Cannabis: What UK Evidence Shows

Fibromyalgia is a complex chronic pain condition that affects an estimated 1.5 to 2 million people in the UK. Standard treatments include pregabalin, duloxetine, and amitriptyline, but many patients find these only partially effective with significant side effects. Medical cannabis is now a recognised private treatment option for fibromyalgia in Britain.

The pathway to access involves consulting with a specialist doctor at a private clinic. Releaf at releaf.co.uk is the largest provider, having issued over 181,000 prescriptions to date. Their 50-plus doctors include specialists experienced with fibromyalgia specifically. A consultation costs 99 pounds, refunded if treatment is deemed inappropriate.

For fibromyalgia, prescriptions often involve a combination of CBD-rich oils for daytime pain management and THC-containing products for evening pain relief and sleep improvement. Many fibromyalgia patients experience comorbid insomnia and anxiety, making cannabis-based treatment particularly relevant as it can address multiple symptoms simultaneously.

Releaf's operational scale means short wait times. They process approximately 1,200 orders daily with 152 staff. Their Trustpilot profile shows 4.7 from nearly 7,000 reviews, with patients regularly noting the thoroughness of consultations. Becky Hyde wrote in April 2026 that staff were "very lovely and thorough in determining whether it was the right direction for me."

The Releaf+ subscription includes membership benefits like preferential medication pricing and legal protection through Irwin Mitchell. This is something no competing clinic, including Alternaleaf, Curaleaf, or Mamedica, currently offers.

Fibromyalgia patients researching medical cannabis in the UK should know that all four major clinics are CQC-registered and legitimate. However, Releaf's combination of volume, consistency, legal support, and patient satisfaction data makes them the most evidence-backed choice.